Skip to main content
Vineet Laboratories Limited logo

Vineet Laboratories Limited — Investor Relations & Filings

Ticker · VINEETLAB ISIN · INE505Y01010 LEI · 98450053FEE2D64C6147 BSE.NS Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2025-05-06 Regulatory Filings
Country IN India
Listing BSE.NS VINEETLAB

About Vineet Laboratories Limited

http://vineetlabs.co.in/

Vineet Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and API intermediates. The company focuses on producing high-quality chemical compounds through advanced research and development, catering to diverse therapeutic segments including anti-retroviral, anti-diabetic, and anti-hypertensive treatments. Its core operations involve the synthesis of complex molecules and fine chemicals, supported by manufacturing facilities that adhere to rigorous quality management systems. Vineet Laboratories provides custom synthesis and contract manufacturing services, positioning itself as a technical partner for global healthcare organizations. The company emphasizes process optimization and cost-effective production to deliver reliable chemical solutions for large-scale pharmaceutical applications.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-06 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (64 characters) and contains no substantive content, financial data, or any indication of report type. It appears to be a placeholder or an empty document with no meaningful information. Given the lack of content, it cannot be classified as a full report or detailed filing. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2025-05-06 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-28 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate addressed to the Compliance Officer of Vineet Laboratories Limited, certifying that no securities were received for dematerialization/rematerialization during the quarter ended 31.03.2025. It references Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The document is a compliance certificate rather than a financial report or announcement of financial results. It is short (986 characters) and serves as an attestation letter. According to the rules, such officer certifications or attestations should be classified as Regulatory Filings (RNS).
2025-04-16 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 89 characters) and contains no substantive content, financial data, or any indication of report type. It appears to be a placeholder or an empty document with no meaningful information. Given the lack of content, the best classification is Regulatory Filings (RNS) as a fallback category for miscellaneous or non-informative filings.
2025-03-25 English
Copy of Newspaper Publication
Regulatory Filings
2025-02-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.